Daratumumab monotherapy for treating relapsed and refractory multiple myeloma

Supporting evidence

• Evaluation report

• Committee papers (TA783) (PDF 2.52 MB)

  Published:

  13 April 2022

• Appraisal consultation committee papers (TA510) (PDF 28.74 MB)

  Published:

  14 March 2018

• Final appraisal determination committee papers (TA510) (PDF 2.59 MB)

  Published:

  14 March 2018